Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current limitations of gene therapy for rare pediatric diseases: Lessons learned from clinical experience with AAV vectors

1 Nov 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Viral Infections and Immunology Research
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38043983
DOI: 10.1016/s0929-693x(23)00227-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current limitations of gene therapy for rare pediatric diseases: Lessons learned from clinical experience with AAV vectorsPMID 38043983Read ↗

Advances in AAV-mediated gene replacement therapy for pediatric monogenic neurological disordersSemantic proximity Read ↗

Viral gene therapy for paediatric neurological diseases: progress to clinical realitySemantic proximity Read ↗

AAV-Based Gene Therapy: Opportunities, Risks, and Scale-Up StrategiesSemantic proximity Read ↗

AAV vectors: The Rubik’s cube of human gene therapySemantic proximity Read ↗

Adeno-associated virus vector-based gene therapies for pediatric diseasesSemantic proximity Read ↗

The clinical landscape for AAV gene therapiesSemantic proximity Read ↗

Successes and challenges in clinical gene therapySemantic proximity Read ↗

Viral Vectors in Gene Replacement TherapySemantic proximity Read ↗

In vivo applications and toxicities of AAV-based gene therapies in rare diseasesSemantic proximity Read ↗

Gene therapy on the moveSemantic proximity Read ↗

Access to gene therapy for rare diseases when commercialization is not fit for purposeSemantic proximity Read ↗

The Bespoke Gene Therapy Consortium: facilitating development of AAV gene therapies for rare diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.